HUGE logo

FSD Pharma (HUGE) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$2.76 M
-$14.22 M-83.76%

December 31, 2023


Summary


Performance

HUGE Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHUGEbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$3.31 M
+$1.98 M+148.58%

June 30, 2024


Summary


Performance

HUGE Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherHUGEbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

HUGE Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-83.8%-41.7%
3 y3 years-84.3%-92.3%
5 y5 years-82.2%-55.9%

HUGE Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.2%at low-90.6%-59.8%
5 y5-year-92.2%at low-93.4%-59.8%
alltimeall time-92.2%-100.0%-93.4%-99.8%

FSD Pharma Cash And Cash Equivalents History

DateAnnualQuarterly
Jun 2024
-
$3.31 M(+148.6%)
Mar 2024
-
$1.33 M(-51.8%)
Dec 2023
$2.76 M(-83.8%)
$2.76 M(-24.1%)
Sep 2023
-
$3.63 M(-35.9%)
Jun 2023
-
$5.67 M(-38.5%)
Mar 2023
-
$9.22 M(-45.7%)
Dec 2022
$16.98 M(-51.8%)
$16.98 M(-28.5%)
Sep 2022
-
$23.75 M(-24.9%)
Jun 2022
-
$31.62 M(+10.7%)
Mar 2022
-
$28.57 M(-19.0%)
Dec 2021
$35.26 M(+101.2%)
$35.26 M(-10.3%)
Sep 2021
-
$39.32 M(-9.0%)
Jun 2021
-
$43.20 M(-13.3%)
Mar 2021
-
$49.84 M(+184.4%)
Dec 2020
$17.52 M(+193.7%)
$17.52 M(+25.7%)
Sep 2020
-
$13.94 M(+42.2%)
Jun 2020
-
$9.80 M(+66.3%)
Mar 2020
-
$5.89 M(-1.2%)
Dec 2019
$5.97 M
$5.97 M(+8.9%)
Sep 2019
-
$5.48 M(-26.9%)
DateAnnualQuarterly
Jun 2019
-
$7.50 M(-41.5%)
Mar 2019
-
$12.81 M(-17.4%)
Dec 2018
$15.52 M(+311.7%)
$15.52 M(-40.7%)
Sep 2018
-
$26.15 M(+8.5%)
Jun 2018
-
$24.11 M(+908.5%)
Mar 2018
-
$2.39 M(+38.9%)
Feb 2018
-
$1.72 M(>+9900.0%)
Dec 2017
$3.77 M(>+9900.0%)
-
Nov 2017
-
$10.10 K(-27.9%)
Aug 2017
-
$14.00 K(-8.5%)
Aug 2017
$14.00 K(+97.2%)
-
May 2017
-
$15.30 K(+115.5%)
Aug 2016
$7100.00(>+9900.0%)
$7100.00
Aug 2015
$0.00(-100.0%)
-
Dec 2014
$204.10 K(-81.8%)
-
Dec 2013
$1.12 M(+4147.0%)
-
Dec 2012
$26.40 K(-94.6%)
-
Dec 2011
$485.00 K(-26.2%)
-
Dec 2010
$657.50 K(+2.9%)
-
Dec 2009
$638.90 K
-

FAQ

  • What is FSD Pharma annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for FSD Pharma?
  • What is FSD Pharma annual cash & cash equivalents year-on-year change?
  • What is FSD Pharma quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for FSD Pharma?
  • What is FSD Pharma quarterly cash and cash equivalents year-on-year change?

What is FSD Pharma annual cash & cash equivalents?

The current annual cash & cash equivalents of HUGE is $2.76 M

What is the all time high annual cash & cash equivalents for FSD Pharma?

FSD Pharma all-time high annual cash & cash equivalents is $35.26 M

What is FSD Pharma annual cash & cash equivalents year-on-year change?

Over the past year, HUGE annual cash & cash equivalents has changed by -$14.22 M (-83.76%)

What is FSD Pharma quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of HUGE is $3.31 M

What is the all time high quarterly cash and cash equivalents for FSD Pharma?

FSD Pharma all-time high quarterly cash and cash equivalents is $49.84 M

What is FSD Pharma quarterly cash and cash equivalents year-on-year change?

Over the past year, HUGE quarterly cash and cash equivalents has changed by -$2.36 M (-41.69%)